Aridis Pharmaceuticals, Inc.

ARDS · OTC
Analyze with AI
9/30/2023
6/30/2023
3/31/2023
12/31/2022
Assets
Cash & Equivalents$35$19$1,320$4,876
Short-Term Investments$0$0$0$0
Receivables$517$300$100$1,240
Inventory$0$0$0$0
Other Curr. Assets$3,558$3,565$5,146$5,510
Total Curr. Assets$4,110$3,884$6,566$11,626
Property Plant & Equip (Net)$1,584$1,757$1,947$2,147
Goodwill$0$0$0$0
Intangibles$13$14$15$17
Long-Term Investments$0$0$0$0
Tax Assets$0$0$0$0
Other NC Assets$827$827$906$905
Total NC Assets$2,424$2,598$2,868$3,069
Other Assets$0$0$0$0
Total Assets$6,534$6,482$9,434$14,695
Liabilities
Payables$5,410$6,237$4,119$2,308
Short-Term Debt$3,986$5,293$2,798$4,838
Tax Payable$0$0$0$0
Deferred Revenue$380$380$19,091$20,173
Other Curr. Liab.$7,706$8,484$9,423$9,579
Total Curr. Liab.$17,482$20,394$35,431$36,898
LT Debt$854$1,002$1,148$1,292
Deferred Rev, NC$0$0$737$737
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$854$1,002$1,885$2,029
Other Liabilities$0$0$0$0
Cap. Leases$1,430$1,565$1,698$1,830
Total Liabilities$18,336$21,396$37,316$38,927
Equity
Pref Stock$0$0$0$0
Common Stock$5$4$4$3
Retained Earnings-$190,421-$190,338-$202,482-$195,666
AOCI$7,787$6,526$5,912$5,051
Other Equity$170,827$168,894$168,684$166,380
Total Equity-$11,802-$14,914-$27,882-$24,232
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$6,534$6,482$9,434$14,695
Net Debt$4,805$6,276$2,626$1,254